Uviquity, Inc. Market Research Report

Background

Overview

Uviquity, Inc., founded in 2022 and headquartered in Raleigh, North Carolina, is a deep-tech startup specializing in the development of solid-state far-UVC semiconductor light sources. These light sources are designed to deliver safe, continuous, and chemical-free disinfection for air, food, and water applications. By harnessing proprietary photonic integrated circuits, Uviquity aims to revolutionize pathogen control across various industries.

Mission and Vision

Uviquity's mission is to provide safe, healthy, and disease-free environments by transforming how we protect air, water, and food—without chemicals, waste, or compromises. The company envisions a world where pathogens are no longer a daily threat, and protection is seamlessly integrated into the spaces we live and work.

Industry Significance

The global disinfection market is experiencing significant growth, driven by increasing awareness of hygiene and the need for pathogen control. Uviquity's innovative approach positions it at the forefront of this market, offering a scalable and human-safe solution that addresses the limitations of traditional disinfection methods.

Key Strategic Focus

Core Objectives

Innovation in Disinfection Technology: Develop and commercialize solid-state far-UVC light engines that provide continuous, chemical-free disinfection.

Scalability and Integration: Create compact, energy-efficient solutions that can be seamlessly integrated into various applications, from air handling systems to consumer appliances.

Global Health Impact: Enhance public health by reducing the prevalence of airborne and surface-borne pathogens through continuous disinfection.

Areas of Specialization

Far-UVC Light Technology: Specializing in the development of far-UVC light sources that are safe for continuous human exposure while effectively inactivating pathogens.

Semiconductor Photonics: Utilizing advanced semiconductor materials and photonic integrated circuits to produce efficient and scalable disinfection solutions.

Key Technologies Utilized

Photonic Integrated Circuits (PICs): Employing PICs to couple blue laser light into frequency-doubling waveguides, enabling the generation of spectrally pure 222 nm far-UVC light.

Second Harmonic Generation (SHG): Utilizing SHG to double the frequency of blue laser light, producing the desired far-UVC wavelength.

Primary Markets Targeted

Air Disinfection: Public and private spaces requiring continuous pathogen control.

Food Processing and Agriculture: Facilities needing chemical-free pathogen control to ensure food safety and sustainability.

Water Purification: Systems requiring chemical-free disinfection to provide clean water at any scale.

Financials and Funding

Funding History

Uviquity has secured a total of $16.8 million in funding, with the most recent being a $6.6 million seed funding round completed in May 2025.

Recent Funding Round

Amount Raised: $6.6 million

Date: May 2025

Lead Investor: Emerald Development Managers

Participating Investors: AgFunder and MANN+HUMMEL

Utilization of Capital

The funds are allocated to accelerate research and development efforts, focusing on the commercialization of Uviquity's proprietary far-UVC semiconductor technology. This includes scaling production capabilities and expanding market reach across various applications.

Pipeline Development

Key Pipeline Candidates

Uviquity is in the process of developing its solid-state far-UVC light engine, a compact, energy-efficient solution capable of continuous, chemical-free disinfection. The technology is designed to be integrated into various applications, including air handling systems, food processing equipment, and water purification systems.

Stages of Development

Research and Development: Ongoing efforts to refine the technology and prepare for commercialization.

Prototype Development: Plans to develop prototypes in the near future, with customer samples expected in 2026.

Target Conditions

The technology aims to address pathogen control in air, food, and water, providing continuous disinfection without the use of chemicals.

Anticipated Milestones

Prototype Completion: Expected in the near future.

Customer Samples: Planned for 2026.

Pilot Production: Anticipated in 2027.

Technological Platform and Innovation

Proprietary Technologies

Far-UVC Light Engine: A semiconductor chip that generates human-safe, pathogen-eliminating far-UVC light.

Significant Scientific Methods

Second Harmonic Generation (SHG): A process used to double the frequency of blue laser light, producing the desired far-UVC wavelength.

Photonic Integrated Circuits (PICs): Integrated circuits that couple blue laser light into frequency-doubling waveguides, enabling efficient far-UVC light generation.

AI-Driven Capabilities

While Uviquity's current focus is on photonic and semiconductor technologies, the integration of AI-driven capabilities may be explored in future developments to enhance system efficiency and adaptability.

Leadership Team

Scott Burroughs – Chief Executive Officer

Professional Background: Serial entrepreneur with deep expertise in photonics and semiconductors.

Key Contributions: Co-founder of Uviquity, leading the company's strategic vision and development efforts.

Russ Kanjorski – Chief Commercial Officer

Professional Background: Extensive experience in commercializing advanced technologies across various industries.

Key Contributions: Overseeing Uviquity's market strategy and partnerships to drive adoption of the technology.

Brent Fisher – Chief Scientist

Professional Background: Expert in photonics and semiconductor technologies, with a focus on light-based pathogen control.

Key Contributions: Leading the research and development of Uviquity's far-UVC light engine technology.

Competitor Profile

Market Insights and Dynamics

The disinfection market is rapidly evolving, with increasing demand for chemical-free and continuous pathogen control solutions. Uviquity's innovative approach positions it to capitalize on this growing trend, offering a scalable and human-safe alternative to traditional disinfection methods.

Competitor Analysis

Far UV Technologies: Provides air and surface disinfection devices operating autonomously to reduce pathogens in occupied spaces.

OXbyEL: Specializes in water treatment solutions focusing on environmental sectors, offering technologies for the destruction of organic fluorine in water.

BlueGreen Water Technologies: Involved in environmental restoration and water safety, providing solutions for the prevention and remediation of harmful algal blooms.

Enviolet: Specializes in UV-based technologies for industrial wastewater treatment and recycling, offering robust UV reactors and systems for advanced oxidation processes.

BridgeLux: Specializes in high-performance solid-state lighting solutions within the commercial and industrial lighting sector, offering a range of LED products.

Strategic Collaborations and Partnerships

Uviquity has secured strategic partnerships with investors such as Emerald Development Managers, AgFunder, and MANN+HUMMEL, which provide financial support and industry expertise to accelerate the commercialization of its technology.

Operational Insights

Uviquity's compact, energy-efficient far-UVC light engine offers a distinct competitive advantage over traditional disinfection methods, enabling seamless integration into various applications without the bulk and safety concerns associated with older technologies.

Strategic Opportunities and Future Directions

Uviquity is well-positioned to expand its market presence by targeting sectors such as healthcare, agriculture, and water treatment, where the demand for continuous, chemical-free disinfection solutions is increasing. The company's innovative technology and strategic partnerships provide a solid foundation for future growth and industry leadership.